×
Back to Agenda
LS40 Promoting DX (Digital Transformation) in Risk Communication to Patients
Session Chair(s)
Kazuhiko Ishida, MSC, RPH
Director, Pharmacovigilance, Astellas Pharma Inc., Japan
Speaker(s)
Michiko Yamamoto, PHD
Pharmaceutical Sciences/Visiting Professor, Graduate School of Kumamoto University, Japan
Shinya Takemoto, MSC
Group Manager, Safety Information Strategy Group, Risk Communication Department, Chugai Pharmaceutical Co., Ltd., Japan
Have an account?